Semaglutide Initially developed to treat type 2 diabetes, Semaglutide has shown promising results in weight management
Gastrointestinal disorders were the most common adverse events with semaglutide, typically transient, of mild-to-moderate severity, occurring during dose escalation, and infrequently leading to treatment discontinuation
During this session, your BMI, health history, medications, and personal weight loss goals are reviewed
It has shown promise in animal studies for promoting tissue healing, including in joints, by accelerating the repair of muscles, tendons, and ligaments, reducing inflammation, and potentially aiding in pain relief